US8420774B2ActiveUtilityPatentIndex 83
Decorating hydroxyapatite biomaterials with modular biologically active molecules
Est. expiryDec 1, 2029(~3.4 yrs left)· nominal 20-yr term from priority
C07K 14/50B05D 1/18C07K 14/52C07K 14/51B05D 1/28
83
PatentIndex Score
13
Cited by
4
References
7
Claims
Abstract
A modular peptide design strategy wherein the modular peptide has two functional units separated by a spacer portion is disclosed. More particularly, the design strategy combines a hydroxyapatite-binding portion and a biomolecule-derived portion. The modular peptides have improved non-covalent binding to the surface of the HA-based materials, and are capable of initiating osteogenesis, angiogenesis, and/or osteogenic differentiation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A modular peptide for non-covalently binding to a surface of a biomaterial, the modular peptide comprising: a hydroxyapatite-binding portion, a spacer portion, and a biomolecule-derived portion, wherein the hydroxyapatite-binding portion comprises an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6.
2. The modular peptide as set forth in claim 1 wherein the biomaterial is selected from the group consisting of hydoxyapatite and hydroxyapatite-based materials.
3. The modular peptide as set forth in claim 1 wherein the spacer portion is an amino acid sequence capable of forming an α-helix.
4. The modular peptide as set forth in claim 1 wherein the spacer portion is SEQ ID NO:7.
5. The modular peptide as set forth in claim 1 wherein the biomolecule-derived portion is a growth factor capable of initiating at least one of osteogenesis, angiogenesis, and osteogenic differentiation.
6. The modular peptide as set forth in claim 5 wherein the growth factor comprises an amino acid sequence selected from the group consisting of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11.
7. The modular peptide as set forth in claim 1 having the sequence selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO: 14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, and SEQ ID NO:18.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.